A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday. Officials with the Michigan health system said the study found the drug “significantly” decreased the death rate of patients involved in the analysis.
Henry Ford Health report: Hydroxychloroquine ‘significantly’ decreased death rate added by World Tribune on
View all posts by World Tribune →